COVID-19 RAPID ANTIGEN TESTS
The INDICAID® COVID-19 Rapid Antigen Test is a lateral flow immunoassay designed for the objective identification of SARS-CoV-2 antigens. Antigen tests are designed to detect proteins from the virus that causes COVID-19 through swab specimens taken from a patient’s nose.
INDICAID® COVID-19 RAPID ANTIGEN TEST FOR POINT-OF-CARE IS A RELIABLE INDICATOR IN THE LABORATORY, OFFICE, ATTENDING EVENTS & MORE.
NOW, WE’RE OFFERING OUR FDA EUA APPROVED INDICAID® OTC FOR SELF-TESTING AT-HOME.
STAY POSITIVE WHILE STAYING NEGATIVE WITH INDICAID® COVID-19 RAPID ANTIGEN TESTING.
RESULTS IN JUST 20 MINUTES
ACCURATE RESULTS FOR PEACE-OF-MIND
RESULTS IN 20 MINUTES
BATCH-COLLECTION AND BULK-TESTING OF SAMPLES
NO EQUIPMENT OR TRAINING NECESSARY
GENTLE SELF-COLLECTION WITH SHALLOW, NASAL SAMPLES
The US FDA has extended their emergency useauthorization (EUA) for the INDICAID®
COVID-19 Rapid Antigen Test to cover serial testing for asymptomatic individuals when tested 3 times, at least 48 hours apart over five days. The update extends the use of INDICAID® as a screening test, providing an additional accurate and reliable testing option for schools, workplaces, and communities.
“It busts the myth that antigen tests could only detect symptomatic patients and shows that high-quality antigen tests can be sensitive, accurate, and reliable to be used for population screening.”
Product performance against new variants are evaluated on an ongoing basis.
PHASE Scientific is a high-growth biotech company founded by bioengineers from a prestigious research university in Los Angeles, California. We build tools that empower people by giving them better information about their health.
With our office and warehouses in Los Angeles, California, Sales & Marketing Office in Atlanta, Georgia, and corporate headquarters in Hong Kong, our global footprint includes R&D and manufacturing facilities in Southern California and offices in Mainland China.